Literature DB >> 19025444

Insulin resistance and beta cell function as prognostic indicator in multi-organ dysfunction syndrome.

Sidhartha Das1, Bijay Misra, Laxmidhar Roul, Noas Tobias Minz, Madhusmita Pattnaik, Mirza Asraf Ali Baig.   

Abstract

Insulin resistance (IR) is a major factor in the pathogenesis of sepsis. Critically ill patients with multi-organ dysfunction syndrome (MODS), diagnosed as per modified Acute Physiology and Chronic Health Evaluation II (modified APACHE II) score criteria and admitted to the medical ward in our hospital, were assessed for IR and beta cell function by using the homeostasis model assessment A (HOMA-A) and HOMA-B models, respectively. Of 80 consecutive patients, 60 were followed up to day 7; 16 patients died and 4 did not agree to follow up. The mean value of IR in all the 80 patients studied on the day 1 of hospitalization was 6.67 +/- 10.65. The initial high values of serum insulin and IR were significantly reduced (p < 0.05) as these patients recovered from their critical illness. Of those who died, the first day mean insulin levels were high (13.80 +/- 14.72 micro/ml as well as IR 5.14 +/- 6.76 values), but they had statistically low beta cell function (46.45 +/- 433.64%) as compared to those who recovered (227.60 +/- 430.36%; p < 0.05). This suggests that, beta cell overexhaustion occurs in critically ill patients, because it was required to overcome the prevailing state of IR and has more bearing in patients having less than 4 organ failures. beta cell failure ensued from the onset in those who were more moribund and had more than four organs failing or those who died. IR and beta cell function are reliable indicators of the state of severity of critical illness, and they corroborated with mortality in patients with MODS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19025444     DOI: 10.1089/met.2008.0025

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  6 in total

Review 1.  Hyperglycemia in critical illness: a review.

Authors:  David Brealey; Mervyn Singer
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

2.  Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance.

Authors:  Shahinul Alam; Kamrul Anam; Saiful Islam; Golam Mustafa; Ayub Al Mamun; Nooruddin Ahmad
Journal:  J Clin Exp Hepatol       Date:  2018-06-20

3.  Relationship Between Beta Cell Dysfunction and Severity of Disease Among Critically Ill Children: A STROBE-Compliant Prospective Observational Study.

Authors:  Ping-Ping Liu; Xiu-Lan Lu; Zheng-Hui Xiao; Jun Qiu; Yi-Min Zhu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Impaired Pancreatic β-Cell Function in Critically Ill Children.

Authors:  Shereen A Mohamed; Nora E Badawi; Hoiyda A AbdelRasol; Hossam M AbdelAziz; Nirvana A Khalaf; Remon M Yousef
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

5.  Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome.

Authors:  Sonu Sama; Gaurav Jain; Ravi Kant; Ajeet S Bhadoria; Manisha Naithani; Ajit Kumar
Journal:  Indian J Crit Care Med       Date:  2021-12

6.  MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.

Authors:  Catalin Vasilescu; Simona Rossi; Masayoshi Shimizu; Stefan Tudor; Angelo Veronese; Manuela Ferracin; Milena S Nicoloso; Elisa Barbarotto; Monica Popa; Oana Stanciulea; Michael H Fernandez; Dan Tulbure; Carlos E Bueso-Ramos; Massimo Negrini; George A Calin
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.